UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2020-10, Vol.21 (10), p.1269-1282

2020

Volltextzugriff (PDF)

On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design

Statistics in medicine, 2021-05, Vol.40 (10), p.2321-2338

2021

Volltextzugriff (PDF)

Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpoints

Health services and outcomes research methodology, 2024-03, Vol.24 (1), p.14-45

2024

Volltextzugriff (PDF)

Comments on “Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects” by Jose Jimenez, Viktoriya Stalbovskaya, and Byron Jones. Pharm Stat. 18:287‐303, 2019, DOI: 10.1002/pst.1923

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2020-09, Vol.19 (5), p.733-735

Kundu, Madan G.

2020

Volltextzugriff (PDF)

Recipient Survival after Orthotopic Liver Transplantation: Interpretable Machine Learning Survival Tree Algorithm for Patient-Specific Outcomes

Journal of the American College of Surgeons, 2023-04, Vol.236 (4), p.563-572

2023

Volltextzugriff (PDF)

A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor

Clinical cancer research, 2023-09, Vol.29 (18), p.3659-3667

2023

Volltextzugriff (PDF)

Social Cognitive Career Theory Predictors of Goal Persistence in African American College Students With Disabilities

Rehabilitation counseling bulletin, 2024-01, Vol.67 (2), p.83-93

2024

Volltextzugriff (PDF)

Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial

European journal of cancer (1990), 2021-09, Vol.154, p.35-45

2021

Volltextzugriff (PDF)

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)

Clinical cancer research, 2021-09, Vol.27 (18), p.4983-4993

2021

Volltextzugriff (PDF)

Survival Tree Provides Individualized Estimates of Survival After Lung Transplant

The Journal of surgical research, 2024-07, Vol.299, p.195-204

2024

Volltextzugriff (PDF)

Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: meta-analyses of published studies

Contemporary clinical trials, 2017-02, Vol.53, p.20-28

2017

Volltextzugriff (PDF)

Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer

Clinical lung cancer, 2022-05, Vol.23 (3), p.214-225

2022

Volltextzugriff (PDF)

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g BRCA Advanced Breast Cancer (BROCADE3 Crossover)

Clinical cancer research, 2021-09, Vol.27 (18), p.4983-4993

2021

Volltextzugriff (PDF)

Corrigendum to “Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies” [Contemp. Clin. Trials 53 (2017) 20–28]

Contemporary clinical trials, 2017-09, Vol.60, p.126-126

2017

Volltextzugriff (PDF)

Adaptive penalties for generalized Tikhonov regularization in statistical regression models with application to spectroscopy data

Journal of chemometrics, 2017-04, Vol.31 (4), p.np-n/a

2017

Volltextzugriff (PDF)

Longitudinal functional models with structured penalties

Statistical modelling, 2016-04, Vol.16 (2), p.114-139

2016

Volltextzugriff (PDF)

Assessing Vocational Rehabilitation Engagement of People With Disabilities: A Factor-Analytic Approach

Rehabilitation counseling bulletin, 2017-04, Vol.60 (3), p.145-154

2017

Volltextzugriff (PDF)

Methicillin-resistant Staphylococcus aureus (MRSA) nasal real-time PCR: a predictive tool for contamination of the hospital environment

Infection control and hospital epidemiology, 2015-01, Vol.36 (1), p.34-39

2015

Volltextzugriff (PDF)

Analysis of the potential risk of central intravenous lines and/or total parenteral nutrition with ventriculoatrial shunts

Child's nervous system, 2015-04, Vol.31 (4), p.563-568

2015

Volltextzugriff (PDF)

Assessing Vocational Rehabilitation Professionals’ Competencies in Taiwan: A Multi-Trait Scaling Analysis

Rehabilitation counseling bulletin, 2017-01, Vol.60 (2), p.108-120

2017

Volltextzugriff (PDF)

Closed-Form Approximation of Correlation Matrix Among Fleming Harrington Test Statistics in MaxCombo Test: Comments on "Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group"

Statistics in biopharmaceutical research, 2023-04, Vol.15 (2), p.340-342

Kundu, Madan G.

2023

Volltextzugriff (PDF)

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

OncoTargets and therapy, 2017-01, Vol.10, p.3177-3186

2017

Volltextzugriff (PDF)

Survival trees based on heterogeneity in time‐to‐event and censoring distributions using parameter instability test

Statistical analysis and data mining, 2021-10, Vol.14 (5), p.466-483

2021

Volltextzugriff (PDF)

Statistics and machine learning methods for EHR data - From data extraction to data analytics, by Hulin Wu et al., CRC Press Statistics and machine learning methods for EHR data - from data extraction to data analytics , by Hulin Wu et al., 2021. Boca Raton, FL:CRC Press, ISBN 978-0-367-44239-2, 327 pages, 130.00 USD, Hardback

Journal of biopharmaceutical statistics, 2021-05, p.1

Kundu, Madan G

2021

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(89)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(45)
Rehabilitation
(18)
Humans
(16)
Female
(11)
Medicine
(11)
Physical Sciences
(10)
Vocational Rehabilitation
(9)
Mathematics
(8)
Oncology
(8)
Physical Medicine And Rehabilitation
(8)
Statistics & Probability
(8)
Adult
(7)
Public Health
(6)
Behavioral Sciences
(5)
Male
(5)
Middle Aged
(5)
Patients
(5)
Pharmacology & Pharmacy
(5)
Self Efficacy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design

Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpoints

Comments on “Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects” by Jose Jimenez, Viktoriya Stalbovskaya, and Byron Jones. Pharm Stat. 18:287‐303, 2019, DOI: 10.1002/pst.1923

Recipient Survival after Orthotopic Liver Transplantation: Interpretable Machine Learning Survival Tree Algorithm for Patient-Specific Outcomes

A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor

Social Cognitive Career Theory Predictors of Goal Persistence in African American College Students With Disabilities

Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)

Survival Tree Provides Individualized Estimates of Survival After Lung Transplant

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: meta-analyses of published studies

Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g BRCA Advanced Breast Cancer (BROCADE3 Crossover)

Corrigendum to “Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies” [Contemp. Clin. Trials 53 (2017) 20–28]

Adaptive penalties for generalized Tikhonov regularization in statistical regression models with application to spectroscopy data

Longitudinal functional models with structured penalties

Assessing Vocational Rehabilitation Engagement of People With Disabilities: A Factor-Analytic Approach

Methicillin-resistant Staphylococcus aureus (MRSA) nasal real-time PCR: a predictive tool for contamination of the hospital environment

Analysis of the potential risk of central intravenous lines and/or total parenteral nutrition with ventriculoatrial shunts

Assessing Vocational Rehabilitation Professionals’ Competencies in Taiwan: A Multi-Trait Scaling Analysis

Closed-Form Approximation of Correlation Matrix Among Fleming Harrington Test Statistics in MaxCombo Test: Comments on "Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group"

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

Survival trees based on heterogeneity in time‐to‐event and censoring distributions using parameter instability test

Suchergebnisse filtern